MMLP vs VRTX · rev $401.3M vs P/E 30, rev $3.33B
Martin Midstream Partners LP (MMLP) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Martin Midstream Partners LP (MMLP) is a oil & gas midstream company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported MMLP revenue for 2026-06-30 was $401.3M. Net income was -$4.1M. MMLP currently screens at market cap $115.2M.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
MMLP currently screens at market cap $115.2M. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the MMLP and VRTX stock pages for the full models.
Not investment advice.